D-Index & Metrics Best Publications
Medicine
Spain
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 103 Citations 60,263 255 World Ranking 4260 National Ranking 55

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Spain Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

The scientist’s investigation covers issues in Internal medicine, Cervical cancer, Gynecology, HPV infection and Cancer. The study incorporates disciplines such as Oncology and Vaccine efficacy in addition to Internal medicine. Xavier Castellsagué usually deals with Cervical cancer and limits it to topics linked to Immunology and Papillomavirus Vaccines and Genital warts.

His study in Gynecology is interdisciplinary in nature, drawing from both Human Papillomavirus DNA Test, Retrospective cohort study, Genotyping, Genotype and Vulva. His Cancer research includes elements of Epidemiology, Risk factor, Pathology and Chlamydia trachomatis. His Epidemiology study combines topics in areas such as Odds ratio and Head and neck cancer.

His most cited work include:

  • Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer (4869 citations)
  • Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study (1555 citations)
  • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. (1307 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Gynecology, Cancer, Cervical cancer and Epidemiology. Within one scientific family, Xavier Castellsagué focuses on topics pertaining to Oncology under Internal medicine, and may sometimes address concerns connected to Genotyping and Retrospective cohort study. His Gynecology study incorporates themes from Incidence, Cervix, Papillomaviridae, Obstetrics and HPV infection.

His biological study spans a wide range of topics, including Odds ratio, Case-control study, Pathology, Cancer research and Dentistry. Xavier Castellsagué works mostly in the field of Odds ratio, limiting it down to topics relating to Risk factor and, in certain cases, Environmental health. His Cervical cancer research integrates issues from Clinical trial and Human papillomavirus.

He most often published in these fields:

  • Internal medicine (44.62%)
  • Gynecology (33.86%)
  • Cancer (33.86%)

What were the highlights of his more recent work (between 2014-2019)?

  • Internal medicine (44.62%)
  • Oncology (23.11%)
  • Cancer (33.86%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Oncology, Cancer, Gynecology and Head and neck cancer. His Odds ratio, Incidence, Case-control study, Confidence interval and HPV infection study are his primary interests in Internal medicine. His Oncology research includes themes of Retrospective cohort study, Pathology, Carcinoma, Confounding and Surrogate endpoint.

He works mostly in the field of Cancer, limiting it down to concerns involving Vulva and, occasionally, Anus and Vagina. His research in Gynecology intersects with topics in Cervical cancer, Cervical intraepithelial neoplasia, Anal cancer and Cervix. The concepts of his Head and neck cancer study are interwoven with issues in Attributable risk, Epidemiology, Head and neck, Larynx and Socioeconomic status.

Between 2014 and 2019, his most popular works were:

  • Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis (376 citations)
  • HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients (357 citations)
  • Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide (211 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Xavier Castellsagué mostly deals with Internal medicine, Case-control study, Oncology, Vaccination and Young adult. His Internal medicine research is multidisciplinary, relying on both Imputation and Allele. The concepts of his Case-control study study are interwoven with issues in Odds ratio, Socioeconomic status, Head and neck cancer and Epidemiology.

His studies deal with areas such as Retrospective cohort study, Genotyping, Carcinoma, Gynecology and HPV vaccines as well as Oncology. Xavier Castellsagué interconnects Cervical cancer, Cervical intraepithelial neoplasia and Randomized controlled trial in the investigation of issues within Vaccination. His study in Young adult is interdisciplinary in nature, drawing from both Incidence and Confidence interval.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

Nubia Muñoz;F. Xavier Bosch;Silvia de Sanjosé;Rolando Herrero.
The New England Journal of Medicine (2003)

8563 Citations

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets.
Lancet Oncology (2010)

2437 Citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler.
The Lancet (2009)

2192 Citations

HPV in the etiology of human cancer

Nubia Munoz;Xavier Castellsague;Amy Berrington De Gonzalez;Lutz Gissmann.
Vaccine. Supplement (2006)

2012 Citations

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.

Silvia de Sanjosé;Mireia Diaz;Xavier Castellsagué;Gary Clifford.
Lancet Infectious Diseases (2007)

1986 Citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud.
The Lancet (2007)

1871 Citations

Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Nubia Muñoz;F. Xavier Bosch;Xavier Castellsagué;Mireia Díaz.
International Journal of Cancer (2004)

1692 Citations

Environmental co-factors in HPV carcinogenesis.

Xavier Castellsagué;F.Xavier Bosch;Nubia Muñoz.
Virus Research (2002)

1684 Citations

Chapter 1: HPV in the etiology of human cancer.

Nubia Muñoz;Xavier Castellsagué;Amy Berrington de González;Lutz Gissmann.
Vaccine (2006)

1646 Citations

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

Rolando Herrero;Xavier Castellsagué;Michael Pawlita;Jolanta Lissowska.
Journal of the National Cancer Institute (2003)

1623 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Xavier Castellsagué

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 185

Suzanne M. Garland

Suzanne M. Garland

University of Melbourne

Publications: 184

Silvia Franceschi

Silvia Franceschi

Centro di Riferimento Oncologico

Publications: 174

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 167

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 163

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 144

Rolando Herrero

Rolando Herrero

International Agency For Research On Cancer

Publications: 142

Paolo Boffetta

Paolo Boffetta

Stony Brook Medicine

Publications: 136

Anna R. Giuliano

Anna R. Giuliano

University of South Florida

Publications: 136

Peter J.F. Snijders

Peter J.F. Snijders

Vrije Universiteit Amsterdam

Publications: 133

Robert D. Burk

Robert D. Burk

Albert Einstein College of Medicine

Publications: 132

Wim Quint

Wim Quint

Erasmus University Rotterdam

Publications: 131

Luisa L. Villa

Luisa L. Villa

Universidade de São Paulo

Publications: 129

Michael Pawlita

Michael Pawlita

German Cancer Research Center

Publications: 114

Susanne K. Kjaer

Susanne K. Kjaer

University of Copenhagen

Publications: 113

Silvia de Sanjosé

Silvia de Sanjosé

University of Barcelona

Publications: 106

Trending Scientists

Giovanni Schiuma

Giovanni Schiuma

LUM University

Deniz Ucbasaran

Deniz Ucbasaran

University of Warwick

Alexander Ljungqvist

Alexander Ljungqvist

Stockholm School of Economics

Weiyao Lin

Weiyao Lin

Shanghai Jiao Tong University

Mohammad Taghi Ahmadian

Mohammad Taghi Ahmadian

Sharif University of Technology

Shoji Kawahito

Shoji Kawahito

Shizuoka University

Kevin L. Kilgore

Kevin L. Kilgore

Case Western Reserve University

Thomas Weyhermüller

Thomas Weyhermüller

Max Planck Society

Anders Holmen

Anders Holmen

Norwegian University of Science and Technology

Craig M. Crews

Craig M. Crews

Yale University

Aleem Siddiqui

Aleem Siddiqui

University of California, San Diego

T-C Wu

T-C Wu

Johns Hopkins University

Claudia Kammann

Claudia Kammann

Hochschule Geisenheim University

Gerold Stucki

Gerold Stucki

University of Lucerne

James M. Bjork

James M. Bjork

Virginia Commonwealth University

Davide Gaiotto

Davide Gaiotto

Perimeter Institute

Something went wrong. Please try again later.